TransThera Biosciences
传信生物
TransThera Biosciences
Biotech/Healthcare
Founded in April 2021, Chuanxin Biotech is dedicated to the commercial development of RNA therapeutics. By introducing globally leading LNP delivery technology, the company has established an integrated mRNA drug discovery and development, as well as scaled manufacturing, platform.
Latest round: Series A (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.